Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.

Cellular Mechanisms of Oxidative Stress and Action in Melanoma. Oxid Med Cell Longev (2015) 0.84

Mechanisms of superoxide signaling in epigenetic processes: relation to aging and cancer. Aging Dis (2015) 0.82

Correction: Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation. PLoS One (2015) 0.75

Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. Clin Epigenetics (2017) 0.75

Inflammation and cancer. Nature (2002) 53.78

A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89

A landscape of driver mutations in melanoma. Cell (2012) 12.61

Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol (1994) 12.40

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet (2006) 10.47

Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol (2003) 8.42

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78

Epigenetics in cancer. Carcinogenesis (2009) 7.49

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00

A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer (1987) 3.80

Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med (2010) 3.60

An elaborate pathway required for Ras-mediated epigenetic silencing. Nature (2007) 3.47

DNA methylation, methyltransferases, and cancer. Oncogene (2001) 3.30

Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science (1998) 2.95

Extending life span by increasing oxidative stress. Free Radic Biol Med (2011) 2.70

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets (2012) 2.55

Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett (2008) 2.27

Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell (2011) 2.23

The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res (2004) 2.12

S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem (2004) 2.09

Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A (1993) 1.86

Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation. Cancer Res (2011) 1.73

DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J Biol Chem (1986) 1.72

A role for reactive oxygen species in endothelial cell anoikis. Circ Res (1999) 1.69

p21ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem (1995) 1.67

Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Mol Cancer (2013) 1.56

Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis. Sci Signal (2012) 1.56

An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol (2002) 1.55

ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene (2011) 1.45

Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med (1999) 1.45

Role of antioxidants in the skin: anti-aging effects. J Dermatol Sci (2010) 1.43

Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res (2006) 1.38

Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J Biol Chem (2003) 1.35

An epigenetic perspective on the free radical theory of development. Free Radic Biol Med (2007) 1.35

Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J Biol Chem (2007) 1.31

Phosphatidylinositol 3-kinase/protein kinase B pathway stabilizes DNA methyltransferase I protein and maintains DNA methylation. Cell Signal (2007) 1.29

Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. Cancer Res (2012) 1.29

Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt. Biochemistry (2003) 1.28

Transcriptional regulation of the human DNA Methyltransferase (dnmt1) gene. Gene (2000) 1.28

Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol Cell Biol (2000) 1.24

Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem (2005) 1.18

Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. Neoplasia (2007) 1.15

Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One (2011) 1.14

Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res (1994) 1.13

Stress and the epigenetic landscape: a link to the pathobiology of human diseases? Nat Rev Genet (2010) 1.13

Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice. Carcinogenesis (2010) 1.07

Melanocyte transformation associated with substrate adhesion impediment. Neoplasia (2006) 1.06

Novel application of S-nitrosoglutathione-Sepharose to identify proteins that are potential targets for S-nitrosoglutathione-induced mixed-disulphide formation. Biochem J (2000) 1.06

Activation of the RacGTPase inhibits apoptosis in human tumor cells. Oncogene (2001) 1.02

Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth. Int J Cancer (2005) 1.01

Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer (2007) 0.99

The new field of epigenomics: implications for cancer and other common disease research. Cold Spring Harb Symp Quant Biol (2004) 0.98

HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal-regulated kinase 1/2 pathway. J Neurochem (2004) 0.97

DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells. Mol Cancer Res (2008) 0.96

Oncogenic H-Ras enhances DNA repair through the Ras/phosphatidylinositol 3-kinase/Rac1 pathway in NIH3T3 cells. Evidence for association with reactive oxygen species. J Biol Chem (2002) 0.96

Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells. Biochem Biophys Res Commun (2010) 0.95

Redox factor-1 (Ref-1) mediates the activation of AP-1 in HeLa and NIH 3T3 cells in response to heat shock. J Biol Chem (1999) 0.93

Epigenetic mechanisms of amyloid-β production in anisomycin-treated SH-SY5Y cells. Neuroscience (2011) 0.92

Superoxide generation in v-Ha-ras-transduced human keratinocyte HaCaT cells. Mol Carcinog (1999) 0.91

Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodules. J Korean Med Sci (2005) 0.91

Driver mutations in melanoma: lessons learned from bench-to-bedside studies. Curr Oncol Rep (2012) 0.89

Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. Oncogene (2006) 0.88

EGF-induced ERK-activation downstream of FAK requires rac1-NADPH oxidase. J Cell Physiol (2011) 0.88

Ras and Nox: Linked signaling networks? Free Radic Biol Med (2009) 0.87

Epigenetic reprogramming as a key contributor to melanocyte malignant transformation. Epigenetics (2011) 0.86

Oncogenic H-Ras, FK228, and exogenous H2O2 cooperatively activated the ERK pathway in selective induction of human urinary bladder cancer J82 cell death. Mol Carcinog (2010) 0.83

Extension of the lifespan of cultured normal human diploid cells by vitamin E: a reevaluation. Proc Natl Acad Sci U S A (1977) 0.83

Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells. Int J Cancer (2011) 0.82

Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells. J Invest Dermatol (2008) 0.82

V-Ha-Ras overexpression induces superoxide production and alters levels of primary antioxidant enzymes. Antioxid Redox Signal (2001) 0.82

Endothelial nitric oxide synthase uncoupling as a key mediator of melanocyte malignant transformation associated with sustained stress conditions. Free Radic Biol Med (2011) 0.79